Serono releases details of global share offer

Production at Serono's plant in Corsier sur Vevey Keystone

The Geneva-based biotechnology company, Serono, says proceeds from its global share offering will total around SFr1.45 billion after expenses.

This content was published on July 27, 2000 - 09:43

The SFr3 billion offering prices bearer shares at SFr1,550 each and American Depositary shares at $23.49 (SFr38.75). Forty ADSs therefore equal one bearer share.

Serono said the new ADSs will begin trading on the New York Stock Exchange on Thursday, the same day as the new bearer shares go public on the Swiss Exchange.

The company, formerly known as Ares-Serono, says the proceeds of the offering will be used to finance its activities and expand its business through alliances and acquisitions.

Serono is the world's third largest biotechnology company.

Before the offering, the company's founding Bertarelli family held 70 per cent of the share capital and 79 per cent of the voting rights. It still retains more than 50 per cent of the share capital and 66 per cent of the voting rights.

Serono will be one of five companies to be added to the Swiss Exchange's blue chip SMI index on October 2, bringing the total number of firms in the index to 30.


This article was automatically imported from our old content management system. If you see any display errors, please let us know:

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?